409 related articles for article (PubMed ID: 19130883)
21. Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis.
Carro E; Trejo JL; Gerber A; Loetscher H; Torrado J; Metzger F; Torres-Aleman I
Neurobiol Aging; 2006 Sep; 27(9):1250-7. PubMed ID: 16183170
[TBL] [Abstract][Full Text] [Related]
22. A specific multi-nutrient diet reduces Alzheimer-like pathology in young adult AβPPswe/PS1dE9 mice.
Broersen LM; Kuipers AA; Balvers M; van Wijk N; Savelkoul PJ; de Wilde MC; van der Beek EM; Sijben JW; Hageman RJ; Kamphuis PJ; Kiliaan AJ
J Alzheimers Dis; 2013; 33(1):177-90. PubMed ID: 22914588
[TBL] [Abstract][Full Text] [Related]
23. APP intracellular domain is increased and soluble Abeta is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer disease.
George AJ; Holsinger RM; McLean CA; Laughton KM; Beyreuther K; Evin G; Masters CL; Li QX
Neurobiol Dis; 2004 Jun; 16(1):124-32. PubMed ID: 15207269
[TBL] [Abstract][Full Text] [Related]
24. Characterization of cognition alteration across the course of the disease in APP751SL mice with parallel estimation of cerebral Abeta deposition.
Blanchard J; Decorte L; Noguès X; Micheau J
Behav Brain Res; 2009 Jul; 201(1):147-57. PubMed ID: 19428628
[TBL] [Abstract][Full Text] [Related]
25. Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease.
Wolf SA; Kronenberg G; Lehmann K; Blankenship A; Overall R; Staufenbiel M; Kempermann G
Biol Psychiatry; 2006 Dec; 60(12):1314-23. PubMed ID: 16806094
[TBL] [Abstract][Full Text] [Related]
26. Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging.
Jensen MT; Mottin MD; Cracchiolo JR; Leighty RE; Arendash GW
Neuroscience; 2005; 130(3):667-84. PubMed ID: 15590151
[TBL] [Abstract][Full Text] [Related]
27. Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice.
Cao D; Fukuchi K; Wan H; Kim H; Li L
Neurobiol Aging; 2006 Nov; 27(11):1632-43. PubMed ID: 16236385
[TBL] [Abstract][Full Text] [Related]
28. Special lipid-based diets alleviate cognitive deficits in the APPswe/PS1dE9 transgenic mouse model of Alzheimer's disease independent of brain amyloid deposition.
Koivisto H; Grimm MO; Rothhaar TL; Berkecz R; Lütjohann D D; Giniatullina R; Takalo M; Miettinen PO; Lahtinen HM; Giniatullin R; Penke B; Janáky T; Broersen LM; Hartmann T; Tanila H
J Nutr Biochem; 2014 Feb; 25(2):157-69. PubMed ID: 24445040
[TBL] [Abstract][Full Text] [Related]
29. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
Behav Brain Res; 2013 Mar; 240():146-52. PubMed ID: 23178660
[TBL] [Abstract][Full Text] [Related]
30. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.
Garcia-Alloza M; Robbins EM; Zhang-Nunes SX; Purcell SM; Betensky RA; Raju S; Prada C; Greenberg SM; Bacskai BJ; Frosch MP
Neurobiol Dis; 2006 Dec; 24(3):516-24. PubMed ID: 17029828
[TBL] [Abstract][Full Text] [Related]
31. Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels.
Pacheco-Quinto J; Rodriguez de Turco EB; DeRosa S; Howard A; Cruz-Sanchez F; Sambamurti K; Refolo L; Petanceska S; Pappolla MA
Neurobiol Dis; 2006 Jun; 22(3):651-6. PubMed ID: 16516482
[TBL] [Abstract][Full Text] [Related]
32. Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models.
Patel NV; Gordon MN; Connor KE; Good RA; Engelman RW; Mason J; Morgan DG; Morgan TE; Finch CE
Neurobiol Aging; 2005 Jul; 26(7):995-1000. PubMed ID: 15748777
[TBL] [Abstract][Full Text] [Related]
33. Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease.
Timmer NM; Herbert MK; Kleinovink JW; Kiliaan AJ; De Waal RM; Verbeek MM
Neuropathol Appl Neurobiol; 2010 Oct; 36(6):478-86. PubMed ID: 20831743
[TBL] [Abstract][Full Text] [Related]
34. Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease.
Minkeviciene R; Banerjee P; Tanila H
J Pharmacol Exp Ther; 2004 Nov; 311(2):677-82. PubMed ID: 15192085
[TBL] [Abstract][Full Text] [Related]
35. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
36. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.
Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E
Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673
[TBL] [Abstract][Full Text] [Related]
37. Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis.
Bjelik A; Bereczki E; Gonda S; Juhász A; Rimanóczy A; Zana M; Csont T; Pákáski M; Boda K; Ferdinandy P; Dux L; Janka Z; Sántha M; Kálmán J
Neurochem Int; 2006 Sep; 49(4):393-400. PubMed ID: 16546298
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-beta.
Takechi R; Galloway S; Pallebage-Gamarallage MM; Wellington CL; Johnsen RD; Dhaliwal SS; Mamo JC
Br J Nutr; 2010 Mar; 103(5):652-62. PubMed ID: 19860996
[TBL] [Abstract][Full Text] [Related]
39. Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease.
Sahlin C; Pettersson FE; Nilsson LN; Lannfelt L; Johansson AS
Eur J Neurosci; 2007 Aug; 26(4):882-9. PubMed ID: 17714184
[TBL] [Abstract][Full Text] [Related]
40. Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease.
Filali M; Lalonde R
Brain Res; 2009 Oct; 1292():93-9. PubMed ID: 19643098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
